Intranasal blood-brain barrier bypass enables sequential mitochondria-targeted bioengineered nanolamellar system for ischemic stroke therapy.

Conversely, the number of CD206-positive cells exhibited an increasing trend after different treatments, reaching 1.35, 1.54, 2.35, 7.32 times of that in saline group after BP NSs, BPF, BPPF, and MM@BPPF treatments, respectively (Fig. 9G ).

also in 63,971 other papers